These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 3895644)

  • 21. Ten-year experience with DDAVP in treatment of diabetes insipidus.
    Marek J; Loutocký A; Pacovský V; Zaoral M
    Endokrinologie; 1978 May; 72(2):188-94. PubMed ID: 738214
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Diabetes insipidus--with special reference to DDAVP therapy].
    Shimizu K
    Nihon Rinsho; 1979; 37(4):849-55. PubMed ID: 449070
    [No Abstract]   [Full Text] [Related]  

  • 23. The renal prostaglandin system in central diabetes insipidus: effects of desamino-arginine vasopressin.
    Düsing R; Herrmann R; Kramer HJ
    Adv Prostaglandin Thromboxane Res; 1980; 7():1111-3. PubMed ID: 6245565
    [No Abstract]   [Full Text] [Related]  

  • 24. [Treatment and effects of desmopressin (DDAVP) in patients with central diabetes insipidus (author's transl)].
    Matsui K; Kimura T; Ota K; Iitake K; Yoshinaga K
    Horumon To Rinsho; 1979 Aug; 27(8):891-5. PubMed ID: 487624
    [No Abstract]   [Full Text] [Related]  

  • 25. Effects of vasopressin analogues (DDAVP, DVDAVP) in the form of sublingual tablets in central diabetes insipidus.
    Laczi F; Mezei G; Julesz J; Lázló FA
    Int J Clin Pharmacol Ther Toxicol; 1981 Feb; 19(2):63-8. PubMed ID: 7216552
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Diabetes insipidus. Diagnosis and treatment with DDAVP (Minurin)].
    Steiness I
    Ugeskr Laeger; 1976 Jun; 138(25):1505-10. PubMed ID: 936314
    [No Abstract]   [Full Text] [Related]  

  • 27. Treatment of neonatal diabetes insipidus with desmopressin (DDAVP).
    Yu VY; Werther GA
    Aust Paediatr J; 1980 Dec; 16(4):284-6. PubMed ID: 7016107
    [No Abstract]   [Full Text] [Related]  

  • 28. [Effect of vasopressin on memory in healthy probands and patients with central diabetes insipidus].
    László FA
    Z Gesamte Inn Med; 1983 Aug; 38(15):413-5. PubMed ID: 6636903
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The use of 1-desamino-8-D-arginine vasopressin (DDAVP) in the management of neurogenic diabetes insipidus (multiple etiologies in pediatric patients).
    Brown DR; Uden DL
    Minn Med; 1979 Jun; 62(6):427-32. PubMed ID: 492086
    [No Abstract]   [Full Text] [Related]  

  • 30. [Therapy of central diabetes insipidus with a new synthetic preparation: DDAVP (1-deamino-8-D arginine vasopressin). Preliminary experience in 5 cases].
    Bernasconi S; Vanelli M; Giovannelli G
    Minerva Pediatr; 1975 Feb; 27(5):321-6. PubMed ID: 775282
    [No Abstract]   [Full Text] [Related]  

  • 31. [Therapy for pre-and postoperative diabetes insipidus of parasellar tumors by Desmopressin].
    Taomoto K; Nagashima T; Saya H; Tamaki N; Matsumoto S
    Horumon To Rinsho; 1982 Dec; 30(12):1447-52. PubMed ID: 7160091
    [No Abstract]   [Full Text] [Related]  

  • 32. Desmopressin (DDAVP) for enuresis, diabetes insipidus, and..
    Gaines KK
    Urol Nurs; 2004 Dec; 24(6):520-3. PubMed ID: 15658741
    [No Abstract]   [Full Text] [Related]  

  • 33. [Experiences with the synthetic vasopressin derivative 1-desamino-8-D-arginine vasopressin (DDAVP) in the therapy of diabetes insipidus].
    Schrader D; Frahm H; Freisenhausen HD; Lüdecke D; Krüger HP
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 2():1909-12. PubMed ID: 1030134
    [No Abstract]   [Full Text] [Related]  

  • 34. [Clinical experience with DDAVP (1-deamino-8-D-arginine vasopressin), a new synthetic analog of vasopressin, in the treatment of childhood diabetes insipidus].
    Lebacq E; David L
    Pediatrie; 1975; 30(3):265-270. PubMed ID: 1178251
    [No Abstract]   [Full Text] [Related]  

  • 35. DI patient refractory to vasopressin and dDAVP: absence of antibodies to AVP and dDAVP and inactivating factor in blood serum.
    Slaninová J; Skopková J; Barth T; Lichardus B; Földes O
    Int J Clin Pharmacol Biopharm; 1979 Feb; 17(2):84-6. PubMed ID: 570558
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of swimming on diabetes insipidus treated with DDAVP.
    Haberfellner H
    J Pediatr; 1980 Feb; 96(2):346-7. PubMed ID: 7351615
    [No Abstract]   [Full Text] [Related]  

  • 37. [Mnesic function in 5 patients suffering from central idiopathic diabetes insipidus (author's transl)].
    Gilot P; Crabbe J; Legros JJ
    Acta Psychiatr Belg; 1980; 80(5):755-61. PubMed ID: 7234459
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Marked hypotonic polyuria resulting from nephrogenic diabetes insipidus with partial sensitivity to vasopressin.
    Moses AM; Scheinman SJ; Oppenheim A
    J Clin Endocrinol Metab; 1984 Dec; 59(6):1044-9. PubMed ID: 6490792
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of a new antidiuretic agent, desmopressin acetate (DDAVP).
    Kosman ME
    JAMA; 1978 Oct; 240(17):1896-7. PubMed ID: 691204
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Diabetes insipidus: etiology, diagnosis, and therapy].
    Laczi F
    Orv Hetil; 2002 Nov; 143(46):2579-85. PubMed ID: 12520852
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.